Wu, J., Wang, A., Li, X., Chen, C., Qi, Z., Hu, C., . . . Liu, Q. (2019). Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML). Cancer Biol Ther.
Chicago ZitierstilWu, Jiaxin, et al. "Discovery and Characterization of a Novel Highly Potent and Selective Type II Native and Drug-resistant V299L Mutant BCR-ABL Inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)." Cancer Biol Ther 2019.
MLA ZitierstilWu, Jiaxin, et al. "Discovery and Characterization of a Novel Highly Potent and Selective Type II Native and Drug-resistant V299L Mutant BCR-ABL Inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)." Cancer Biol Ther 2019.